National Health Service (NHS) is the first Health service offering peanut allergy treatment to children in England. NHS England has approved the medication and is projected to benefit 600-700 children in 2021, covering over 2,000 children per year.
After a reaction to peanuts, an oral therapy called Palforzia helps lessen the severity of symptoms, including anaphylaxis. Presently, Peanut allergies affect one in fifty children in the UK.
Clinical tests were conducted at the Evelina London Children’s Hospital, with the girl whose nine-year-old Emily Pratt was the first to benefit and her mother said, “Being on the clinical trials has not altered only my daughter’s life, but also our family lives.”
“The treatment they gave to my daughter has meant that Emily can eat whatever she wants to. We don’t have to worry now whenever she attends any party or function because we had a fear that “our slimmest mistake took her life at risk.”
It is especially noticeable at special occasions like birthdays, Christmas and holidays where they offer foods like cakes, ice cream, and treats that invariable had warnings ‘may contain peanuts.
After the trial gets successful now, we don’t have to worry or keep our eye on her continuously at the parties and playdates or whenever we eat in restaurants without calling ahead to check the menu.
What did the study find?
Palisade and Artemis experiments were undertaken at the Evelina London Children’s Hospital.
According to the Artemis study, six out of ten four to seventeen-year-olds who reacted to roughly 10g of peanut protein at the start of the trial were able to consume a dose of 1,000mg by the end, which is far more than the amount of accidental exposure.
The director of the National Health Service, Professor Stephen Powis said The pioneering not only the children’s lives but also their families’ lives, but European people are the first to enjoy the benefit.